Increases in serum total low-density lipoprotein (LDL) Unknown Status Phase 4 Trials for Simvastatin (DB00641)

Also known as: Increase in low density lipoprotein cholesterol / Increased serum levels of low-density lipoprotein / Increase in low-density lipoprotein cholesterol / Increased Low-Density Lipoprotein Cholesterol / Increased low density lipoprotein cholesterol / Increased serum levels of low-density lipoproteins / High low density cholesterol / Increased low density lipoproteins / Low density lipoprotein increased / Elevated low density lipoprotein cholesterol / Increases in low density lipoprotein / Increase in LDL cholesterol / Subjects With High LDL-Cholesterol / High LDL Cholesterol Level / High LDL / High LDL-C / Increased LDL / High LDL Level / Elevated LDL-Cholesterol (LDL-C) / Elevated LDL / Elevated LDL Cholesterol / LDL increased / Increased low-density lipoprotein / LDL raised / Raised LDL / LDL inc / LDL cholesterol increased / Low density lipoprotein cholesterol increased / Low density lipoprotein cholesterol high

IndicationStatusPhase
DBCOND0102040 (Increases in serum total low-density lipoprotein (LDL))Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00866229Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol LevelTreatment